Kestra Medical Technologies, Ltd.

NasdaqGS:KMTS Stock Report

Market Cap: US$1.0b

Kestra Medical Technologies Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Brian Webster

Chief executive officer

US$757.6k

Total compensation

CEO salary percentage69.0%
CEO tenureno data
CEO ownership0.3%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

Kestra Medical Technologies: A Potential Promising Public Offering

Mar 08

CEO Compensation Analysis

How has Brian Webster's remuneration changed compared to Kestra Medical Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

-US$94m

Jul 31 2024n/an/a

-US$97m

Apr 30 2024US$758kUS$523k

-US$101m

Compensation vs Market: Brian's total compensation ($USD757.56K) is below average for companies of similar size in the US market ($USD3.35M).

Compensation vs Earnings: Insufficient data to compare Brian's compensation with company performance.

CEO

Brian Webster (60 yo)

no data

Tenure

US$757,564

Compensation

Mr. Brian Webster is Founder of Kestra Medical Technologies, Ltd He is President, Chief Executive Officer and Director of Kestra Medical Technologies, Ltd. He served as Chief Executive Officer and Presiden...

Board Members

NamePositionTenureCompensationOwnership
Brian Webster
Founderno dataUS$757.56k0.33%
$ 3.4m
Traci Umberger
Co-Founderno dataUS$498.29k0.13%
$ 1.4m
Raymond Cohen
Independent Directorless than a yearno datano data
Mary Ladone
Independent Directorno datano data0.034%
$ 350.9k
Christopher Gordon
Independent Director9.2yrsno datano data
Jeffrey Schwartz
Independent Chairman2.2yrsno datano data
Maxwell Bikoff
Independent Directorno datano datano data
Alexander AuWerter
Independent Directorno datano datano data
Kevin Reilly
Independent Directorno datano datano data

0.3yrs

Average Tenure

49yo

Average Age

Experienced Board: KMTS's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/09 04:26
End of Day Share Price 2025/03/07 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kestra Medical Technologies, Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.